{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T03:49:08Z","timestamp":1793591348014,"version":"4.5.0"},"reference-count":38,"publisher":"The Journal of Rheumatology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Although pain affects the assessment of disease activity in patients with rheumatoid arthritis (RA), pain is not always directly related to peripheral joint inflammation. Peripheral and central nervous system regulatory mechanisms also affect pain perception. We used regression tree methodology to identify mechanisms most predictive of disease activity after disease-modifying antirheumatic drug (DMARD) treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Disease activity was evaluated using the Disease Activity Score in 28 joints (DAS28) in 176 patients with RA, before and after starting a DMARD. Quantitative sensory testing (QST), including pressure pain thresholds (PPTs), temporal summation, and conditioned pain modulation (CPM), were used to assess pain mechanisms. Regression tree methodology was used to determine the QST modalities most predictive of DAS28 after DMARD treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This analysis identified 4 groups defined by baseline DAS28 category and either knee PPT (a combined measure of peripheral and central nervous system dysregulation) or CPM (a measure of descending pain inhibition). Among patients starting with low\/moderate disease activity, lower knee PPT (PPT \u2264 4.65 kgf) most strongly predicted higher posttreatment disease activity (group 1 mean DAS28 2.8 [SD 1.0] vs group 2 mean DAS28 3.5 [SD 1.0]). Among patients starting with high baseline disease activity, less efficient descending pain modulation (CPM \u2264 1.55) most strongly predicted higher posttreatment disease activity (group 3 mean DAS28 3.4 [SD 1.4] vs group 4 mean DAS28 4.6 [SD 1.1]).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These results highlight the importance of identifying and treating aberrant peripheral and central pain regulation in patients with RA starting or switching DMARD therapy.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.220500","type":"journal-article","created":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T13:25:21Z","timestamp":1673789121000},"page":"741-747","source":"Crossref","is-referenced-by-count":12,"title":["Pain Mechanisms Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Disease-Modifying Antirheumatic Drugs: A Regression Tree Analysis"],"prefix":"10.3899","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4412-3275","authenticated-orcid":false,"given":"Alyssa","family":"Wohlfahrt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8655-1484","authenticated-orcid":false,"given":"Lutfiyya N.","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8881-9664","authenticated-orcid":false,"given":"Jing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7226-3956","authenticated-orcid":false,"given":"Dorothy D.","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9515-1711","authenticated-orcid":false,"given":"Tuhina","family":"Neogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4752-5029","authenticated-orcid":false,"suffix":"III","given":"Clifton O.","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5413-9345","authenticated-orcid":false,"given":"Marcy B.","family":"Bolster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7963-4206","authenticated-orcid":false,"given":"Wendy","family":"Marder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-7818","authenticated-orcid":false,"given":"Daniel J.","family":"Clauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2105-3393","authenticated-orcid":false,"given":"Yvonne C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2023,1,15]]},"reference":[{"key":"2023060503351742000_50.6.741.1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1590\/S1516-31802010000500013","article-title":"Biologics for rheumatoid arthritis: an overview of Cochrane reviews","volume":"128","author":"Singh","year":"2010","journal-title":"Sao Paulo Med J"},{"key":"2023060503351742000_50.6.741.2","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1002\/jcp.27860","article-title":"Strategies toward rheumatoid arthritis therapy; the old and the new","volume":"234","author":"Abbasi","year":"2019","journal-title":"J Cell Physiol"},{"key":"2023060503351742000_50.6.741.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06075-5"},{"key":"2023060503351742000_50.6.741.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2004.08.008"},{"key":"2023060503351742000_50.6.741.5","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2018-213502","article-title":"Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023060503351742000_50.6.741.6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/annrheumdis-2018-213035","article-title":"Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors","volume":"77","author":"Teitsma","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023060503351742000_50.6.741.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15640-7"},{"key":"2023060503351742000_50.6.741.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.066761"},{"key":"2023060503351742000_50.6.741.9","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.autrev.2019.05.007","article-title":"Challenges in the treatment of rheumatoid arthritis","volume":"18","author":"Conigliaro","year":"2019","journal-title":"Autoimmun Rev"},{"key":"2023060503351742000_50.6.741.10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbspin.2018.03.018","article-title":"Predictors of treatment response in rheumatoid arthritis","volume":"86","author":"Lequerr\u00e9","year":"2019","journal-title":"Joint Bone Spine"},{"key":"2023060503351742000_50.6.741.11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/pmt.16.4","article-title":"Pain in rheumatoid arthritis: models and mechanisms","volume":"6","author":"Bas","year":"2016","journal-title":"Pain Manag"},{"key":"2023060503351742000_50.6.741.12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11914-018-0473-5","article-title":"Mechanisms for Joint Pain in Rheumatoid Arthritis (RA): from Cytokines to Central Sensitization","volume":"16","author":"Zhang","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"2023060503351742000_50.6.741.13","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.64"},{"key":"2023060503351742000_50.6.741.14","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/art.41440","article-title":"Association of dysregulated central pain processing and response to disease-modifying anti-rheumatic drug therapy in rheumatoid arthritis","volume":"72","author":"Heisler","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2023060503351742000_50.6.741.15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/acr.23266","article-title":"Association between pain sensitization and disease activity in patients with rheumatoid arthritis: a cross-sectional study","volume":"70","author":"Lee","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2023060503351742000_50.6.741.16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/acr.23994","article-title":"Association of Pain Centralization and Patient-Reported Pain in Active Rheumatoid Arthritis","volume":"72","author":"Heisler","year":"2020","journal-title":"Arthritis Care Res"},{"key":"2023060503351742000_50.6.741.17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/acr.23617","article-title":"Responsiveness of patient-reported outcomes measurement information system measures in rheumatoid arthritis patients starting or switching a disease-modifying antirheumatic drug","volume":"71","author":"Wohlfahrt","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2023060503351742000_50.6.741.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584"},{"key":"2023060503351742000_50.6.741.19","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21649"},{"key":"2023060503351742000_50.6.741.20","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000382"},{"key":"2023060503351742000_50.6.741.21","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.107"},{"key":"2023060503351742000_50.6.741.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.37733"},{"key":"2023060503351742000_50.6.741.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.09.030"},{"key":"2023060503351742000_50.6.741.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2005.02.003"},{"key":"2023060503351742000_50.6.741.25","doi-asserted-by":"publisher","DOI":"10.1097\/01.j.pain.0000460343.46847.58"},{"key":"2023060503351742000_50.6.741.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.07.024"},{"key":"2023060503351742000_50.6.741.27","doi-asserted-by":"publisher","DOI":"10.1007\/s10865-012-9424-2"},{"key":"2023060503351742000_50.6.741.28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.suppl_1.i28"},{"key":"2023060503351742000_50.6.741.29","unstructured":"Breiman L , Friedman J , Stone CJ , Olshen RA. Classification and regression trees. Boca Raton, FL: Chapman & Hall\/CRC, 1984."},{"key":"2023060503351742000_50.6.741.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2009.06.012"},{"key":"2023060503351742000_50.6.741.31","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24017"},{"key":"2023060503351742000_50.6.741.32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/art.39488","article-title":"Association of joint inflammation with pain sensitization in knee osteoarthritis: The Multicenter Osteoarthritis Study","volume":"68","author":"Neogi","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2023060503351742000_50.6.741.33","doi-asserted-by":"publisher","DOI":"10.1002\/art.34646"},{"key":"2023060503351742000_50.6.741.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.04.003"},{"key":"2023060503351742000_50.6.741.35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/papr.12648","article-title":"Association between genetic polymorphisms and pain sensitivity in patients with hip osteoarthritis","volume":"18","author":"Olesen","year":"2018","journal-title":"Pain Pract"},{"key":"2023060503351742000_50.6.741.36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018252"},{"key":"2023060503351742000_50.6.741.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2012.02.021"},{"key":"2023060503351742000_50.6.741.38","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeu056"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.220500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T10:36:30Z","timestamp":1685961390000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.220500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,15]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,1]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.3899\/jrheum.220500"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.220500","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,15]]}}}